Page 131 - Eceptor News Today

Researchers identified a nanobody inhibiting SARS-CoV-2 variants.

Researchers conducted an in vitro analysis to assess the host cell furin-mediated cleavability of the spike protein of the SARS-CoV-2 Omicron (B.1.529) variant.

A new study describes a novel COVID-19 detection technique based on T-cell receptor sequencing.

A recent review paper, published in the MDPI’s specialized journal COVID, highlights key features of the Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – and examines the potential and roadblocks in using renewable marine resources in the fight against the coronavirus disease 2019 (COVID-19).

A new review published in sums up the position of Omicron as a potential threat to human health, especially in the context of controlling this pandemic.

T cell responses were measured to three SARS-CoV-2-associated antigens, as well as the endemic coronaviruses HCoV-OC43 and HCoV-NL63.

For more than two decades, University of Alabama at Birmingham researcher Susan Bellis, Ph.D., has studied how the addition of sialic acid to various proteins increases cancer resistance and oncogenicity.

The messenger substance interleukin-3 produced by the body was previously considered to be pro-inflammatory in bronchial asthma.

Researchers examined antibody escape and cross-domain stabilization in the SARS-CoV-2 Omicron spike protein.

Researchers compared the efficiency of monovalent and bivalent mRNA vaccines against SARS-CoV-2.